Skip to main content
HR logo

HR · Healthcare Realty Trust Inc

Track HR — free
$19.25 +0.04 (+0.21%) At close · Aug 14
Market Cap
$6.60B
Shares
342.72M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$19.25 Open$19.16 Day$19.11–19.43 52W close$16.31–21.87 Avg vol 30d3.8M Short int18.7M · 5.4% float · 4.7d Short vol42% Last earningsJul 31, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 30, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Fair Quant / Vol Very Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +3%
      above
      Price vs 50-day avg −6%
      below
      RSI (14) 30
      neutral
      MACD trend Negative
      52-week position 53%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return −10%
      trailing
      6-month return +4%
      trailing
      YTD return +14%
      this year
      Relative strength −10%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $21 › 200d $19 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +60 funds added
      Insider flow Distributing
      Net -$524.9K over 90 days · 100% sells
      Short interest Falling
      5.45% of float · ▼ -0.6% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      448 holders — near 3-yr high, broad support
      Squeeze score 55
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth −7%
      Y/Y
      EPS growth +61%
      Y/Y
      Buyback $400.1M
      remaining
      Balance sheet $3.9B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 20%
      annualized · 1-yr
      Max drawdown −13%
      past year
      ATR 2.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 30, 2026
      Normalized FFO · full year 2026 Non-GAAP $1.62 – $1.66
      Same Store Cash NOI growth · full year 2026 4.25% – 5%
      Prior guidance period ended · from the 8-K filed Oct 30, 2025
      NAREIT FFO per share · Expected 2025 $1.39 – $1.41
      Normalized FFO per share · Expected 2025 $1.59 – $1.61
      Same Store Cash NOI growth · Expected 2025 4% – 4.75%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +3% Bullish
      Price vs 50-day avg
      −6% Bearish
      RSI (14)
      30 Neutral
      MACD trend
      Negative Bearish
      52-week position
      53% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $21 › 200d $19 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +60 funds added
      Insider flow Distributing
      Net -$524.9K over 90 days · 100% sells
      Short interest Falling
      5.45% of float · ▼ -0.6% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      448 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $16 Now $19 · 53% Range high $22
      vs 200-day avg +3% vs 50-day avg -6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Normalized FFO 143.7M
      +789K Non-real estate depreciation and amortization
      +1.38M Non-cash interest amortization, net
      -13.72M Straight-line amortization, net
      +4.42M Stock-based compensation
      -164K Unconsolidated JV non-cash items
      +0K Other
      -27.05M Maintenance capex
      = FAD 109.36M
      New lease executions 286,000 Q1 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HR
      Healthcare Realty Trust Inc
      this stock
      $6.60B +13.6% -6.9% 5.4%
      WELL
      Welltower Inc.
      $162.55B +26.9% +35.6% 114.6 2.5%
      VTR
      Ventas, Inc.
      $45.66B +18.3% +18.5% 164.8 4.6%
      DOC
      Healthpeak Properties, Inc.
      $14.34B +29.3% +4.5% 59.4 3.5%
      OHI
      Omega Healthcare Investors Inc
      $14.10B +4.9% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      448
      % held
      111.3%
      Net QoQ
      +6.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      383
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      18.7M
      Days to cover
      4.7d
      Change
      -116.7K sh
      View
      Short Volume
      Short vol %
      42%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      9
      Value
      $186
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      43.6%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$524.9K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Donna Shalala
      Amount
      $1.0K–$15.0K
      Traded
      Feb 20, 2019
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $-246.1M
      EPS diluted
      $-0.71
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $400.1M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 31, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $262.1K
      Shares
      15.0K
      Filed
      Sep 4, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 31, 2026
      View
      Investor Relations
      Latest news
      Healthcare Realty Reports Second…
      Published
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      HR -3.6% -9.7% +4.0% -8.4% +13.6%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -4.0% -14.2% -9.8% -12.3% -0.3%

      Capital returns

      Latest dividend
      $0.24 / share · ex Aug 11, 2026
      Cut 22.6%
      Paid (TTM)
      $0.96 / share · 4 payouts
      Dividend yield (TTM, derived)
      4.99%
      Buyback program · as of Jun 30, 2026
      Authorized
      $500.00M
      Spent (derived)
      $99.90M
      Remaining
      $400.10M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1360604 CUSIP 42226K105 13F (30d) 453 filings 423 filers Visit website Investor relations